Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic accumulation of lipids. Antisteatotic effects of cerium oxide nanoparticles (CeO<sub>2</sub>NPs) have recently been shown in animal models of liver disease. However, it is unclear whether the activity of CeO<sub>2...
Main Authors: | Marina Parra-Robert, Eudald Casals, Nuria Massana, Muling Zeng, Meritxell Perramón, Guillermo Fernández-Varo, Manuel Morales-Ruiz, Víctor Puntes, Wladimiro Jiménez, Gregori Casals |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/9/425 |
Similar Items
-
Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases
by: Gregori Casals, et al.
Published: (2021-04-01) -
Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats
by: Bernat Córdoba-Jover, et al.
Published: (2019-10-01) -
Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide
by: Eudald Casals, et al.
Published: (2017-08-01) -
Corrigendum: Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide
by: Eudald Casals, et al.
Published: (2017-12-01) -
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)